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A COMBINED MEDICAL AND SURGICAL STAFF MEETING
will be held
on Wednesday, 22nd March, 1961 at 5:15 p.m.
IN THE COURTAULD LECTURE THEATRE.
Mr. D.P. Burkitt from Makerere College, 
Uganda will talk on "The Commonest Children's 































































































































































“Epidemiology may be 
defined as the study of the 
distribution and 
determinants of diseases 
and injuries in human 



















































































































































1. Is there an association between obesity 
and television watching?
2. Is there an association between being a 



























































Patients with disease, or with Look back to deter-
pre-specified outcome, mine exposure to
and comparison group without possible risk factors
disease or causes
Cohort study
•  To determine causes of disease
Population Patients Incidence of
free from disease followed new cases
•  To determine natural history of disease
Population of Patients Incidence of pre-
patients with followed specified outcomes







































Food Number sick Number well Total people Attack rate
Turkey 24 16 40 60%
mashed potoates & gravy 26 14 40 65%
Green beans 20 20 40 50%































































• Differences       a    versus b    
in % exposed:   a + c                b + d






















































• How dependable is information obtained from the 
past and have data been collected in a reliable 
manner?
• Is recall bias operating? What attempts have 
authors made to assess effect of this potential 
bias?
• Are other biases evident? Are there inequalities in 






















































































Relative Risk = IR of Disease in Exposed Individuals (+) a/a+b








Time Frame For A 
Retrospective Cohort Study Begun in 2008
Develop No Develop No
Disease Disease Disease Disease








Time Frame For A 
Concurrent Cohort Study Begun in 2008
Develop No Develop No
Disease Disease Disease Disease





























































“Epidemiology may be 
defined as the study of the 
distribution and 
determinants of diseases 
and injuries in human 






























































































































































































































 chi‐square test – 2 categorical variables (disease yes/no vs 
gender)
 t test – 1 continuous and 1 categorical variable with only 2 
categories (e.g., blood pressure by race: white vs non‐white; ER 
visits by intervention vs control group)














































































































































































Checklist of Factors to Consider in Reviewing Design 
and Analysis of Case-Control Studies
• Is case-control design appropriate for 
hypothesis being examined or would 
another study design be more appropriate 
or cost-efficient?
• Is sampling method for selection of case 
and control groups clear and 
understandable?
• Have case and control groups been 
selected without regard to exposure 
factor(s) of interest?
• Are incident cases of disease being studied 
or are only prevalent cases included in 
whom the etiology-disease association 






Checklist of Factors to Consider in Reviewing Design 
and Analysis of Case-Control Studies
• Do cases under study reflect a range of 
disease severity or are only select cases 
from a single hospital or ambulatory care 
clinic represented?
• Were appropriate hospital, clinic, and/or 
neighborhood controls selected?
• Have a sufficient number of cases and 
controls been selected to adequately test 
the proposed hypotheses?
• Have cases and controls been matched 
on a limited number of other relevant 
factors and have satisfactory matches 
been achieved?
Yes No Uncertain
   
   
   
   
Checklist of Factors to Consider in Reviewing Design 
and Analysis of Case-Control Studies
• Has categorization of the primary 
exposure factor(s) been carried out into 
appropriate dose/response categories?
• Were individuals involved in either direct 
data collection or record abstraction 
blinded to study hypotheses and/or to 
case/control status?
• Are OR’s and accompanying confidence 
intervals presented to quantify these 
disease: exposure association?
• Have potential confounding variables 
been adequately considered and 
controlled for analytically?
Yes No Uncertain
   
   
   
   
G:rg/Brown files/Brown Med Student Epi Course‐2008‐Cohort 
Studies
• Is use of a prospective design appropriate 
for hypothesis being examined?
• Have exposed and nonexposed study 
subjects been selected from similar 
populations? Has investigator presented a 
sufficient rationale for choice of the study 
population?
• Has exposure status been adequately 
measured and independently validated?
• Have possible changes in exposure status 
since time of initial baseline classification 
been measured and taken into account?
Yes No Uncertain
   
   
   
   
Factors to Consider in Reviewing 





• Have study endpoints been determined 
without regard to exposure status. Are 
persons involved in collection of these data 
unaware of primary study hypotheses?
• Has determination of principal study 
outcome been adequately measured and 
independently validated?
• Have potentially confounding factors been 
measured? Has influence of these factors 
been controlled for analytically?
• Has an acceptable means of determining 
subject follow-up been used and has a 
high follow-up rate been achieved?
Yes No Uncertain
   
   
   
   
Factors to Consider in Reviewing 
Design and Analysis of Longitudinal Studies
• If an acceptable follow-up rate of 
exposed and nonexposed cohorts 
has not been achieved, have the 
sociodemographic or clinical 
characteristics of those unavailable 
for follow-up been compared with 
those remaining under follow-up to 
determine whether groups are 
comparable?
• Did study have adequate power to 
detect differences in principal study 
outcome(s) in exposed and 
nonexposed cohorts?
• Was duration of follow-up sufficient?
Yes No Uncertain
   
   
   
